ObsEva appoints Annette Clancy as Chair of its Board of Directors

– SWITZERLAND, Geneva –  ObsEva SA ( SIX: OBSN | NASDAQ: OBSV), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the appointment of Annette Clancy as Chair of the Board of Directors on May 18, 2022, succeeding Dr.…

DG Innovate announces Peter Tierney as CEO alongside Christopher Theis stepping to Board Chairman

– UK, London –  DG Innovate (LON: DGI), the advanced research and development company pioneering sustainable and environmentally considerate improvements to electric mobility and storage, today announced the appointment of Peter Tierney as the new CEO, effective from 1 July 2022, succeeding Christopher Theis who will assume the role of Executive Chairman for four months before stepping to the role of Non-Executive Chairman from 1 November 2022.…